Market Overview

Benzinga's Top Pre-Market Gainers

Related PPHM
Peregrine Pharmaceuticals Granted Key European Patent for Its Lead Clinical Drug Candidate Bavituximab
Data Presentations at ASCO Demonstrate the Ability of Peregrine Pharmaceuticals' Bavituximab to Activate Tumor Targeting Immune Cells in PD-L1 Negative NSCLC Tumors
Related KSW
Related Companies Successfully Completes KSW Tender Offer
Stocks Hitting 52-Week Highs

KSW (NASDAQ: KSW) soared 20.83% to $4.93 in the pre-market trading. KSW agreed to be acquired by Related Companies for $5.00 per share in cash.

Peregrine Pharmaceuticals (NASDAQ: PPHM) surged 9.78% to $4.94 in the pre-market session. Peregrine Pharmaceuticals is expected to report its Q1 results today.

Regions Financial (NYSE: RF) added 2.17% to $7.53 in the pre-market session. Regions Financial's trailing-twelve-month operating margin is 24.59%.

Tesoro (NYSE: TSO) moved up 2.14% to $41.00 in the pre-market session. Tesoro's PEG ratio is 0.89.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers


Related Articles (KSW + PPHM)

Around the Web, We're Loving...

Get Benzinga's Newsletters